T. Rowe Price Associates’s Asensus Surgical, Inc. ASXC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
|
|||||
2024
Q1 | $43K | Hold |
|
|||||
2023
Q4 | $60K | Hold |
|
|||||
2023
Q3 | $51K | Hold |
|
|||||
2023
Q2 | $94K | Hold |
|
|||||
2023
Q1 | $123K | Sell |
|
|||||
2022
Q4 | $78K | Sell |
|
|||||
2022
Q3 | $134K | Buy |
|
|||||
2022
Q2 | $83K | Sell |
|
|||||
2022
Q1 | $145K | Buy |
|
|||||
2021
Q4 | $220K | Buy |
|
|||||
2021
Q3 | $235K | Buy |
|
|||||
2021
Q2 | $324K | Sell |
|
|||||
2021
Q1 | $335K | Buy |
|
|||||
2019
Q4 | – | Sell |
|
|||||
2019
Q3 | $92K | Buy |
|
|||||
2019
Q2 | $202K | Buy |
|
|||||
2019
Q1 | $351K | Buy |
|
|||||
2018
Q4 | $252K | Sell |
|
|||||
2018
Q3 | $2.32M | Buy |
|
|||||
2018
Q2 | $475K | Buy |
|
|||||
2018
Q1 | $126K | Buy |
|
|||||
2017
Q4 | $142K | Buy |
|